Scynexis: A Novel Antifungal Drug Against Life-Threatening Resistant Infections And Ridiculously Cheap Valuation [Seeking Alpha]
SCYNEXIS, Inc. (SCYX)
Last scynexis, inc. earnings: 11/12 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.scynexis.com/investor-relations
Company Research
Source: Seeking Alpha
Scynexis: A Novel Antifungal Drug Against Life-Threatening Resistant Infections And Ridiculously Cheap Valuation - SCYNEXIS, Inc. (NASDAQ:SCYX) | Seeking Alpha Long Ideas | Healthcare Scynexis: A Novel Antifungal Drug Against Life-Threatening Resistant Infections And Ridiculously Cheap Valuation Feb. 10, 2019 11:48 PM ET About: SCYNEXIS, Inc. (SCYX) by: Bhavneesh Sharma Registered investment advisor, research analyst, newsletter provider Marketplace Vasuda Healthcare Analytics Summary Scynexis recently released impressive data from the open-label FURI trial in invasive candida infections. The stock, which has been slaughtered in the past year, has recovered somewhat but remains ridiculously undervalued even with very conservative market share estimates. A continuous flow of catalysts inluding data releases through 2019-2020 is expected to continue the upward momentum in the stock and achieve our price target. I also present some takeways from a phone call with Scynexis CEO after FURI
Show less
Read more
Impact Snapshot
Event Time:
SCYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SCYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SCYX alerts
High impacting SCYNEXIS, Inc. news events
Weekly update
A roundup of the hottest topics
SCYX
News
- SCYNEXIS, Inc. (NASDAQ: SCYX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- SCYNEXIS, Inc. (NASDAQ: SCYX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- SCYNEXIS to Participate in Guggenheim's 6th Annual Biotechnology Conference [Yahoo! Finance]Yahoo! Finance
- SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology ConferenceGlobeNewswire
- SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference [Yahoo! Finance]Yahoo! Finance
SCYX
Earnings
- 11/13/23 - Miss
SCYX
Sec Filings
- 2/16/24 - Form 4
- 2/13/24 - Form SC
- 2/13/24 - Form SC
- SCYX's page on the SEC website